NeoGenomics Reports 159% Revenue Growth to $63.1 Million and Strong Gains in Profitability in the Second Quarter of 2016

Go back to NeoGenomics Reports 159% Revenue Growth to $63.1 Million and Strong Gains in Profitability in the Second Quarter of 2016
NEOGENOMICS (NASDAQ: NEO) Delayed: 17.04 --0 (-0%)
Previous Close $17.04    52 Week High $9.54 
Open $17.04    52 Week Low $5.49 
Day High $17.04    P/E 426.00 
Day Low $17.04    EPS $0.04 
Volume 14,952